Cargando...
AICAR TREATMENT REDUCES INTERSTITIAL FIBROSIS IN AGING MICE Suppression of the Inflammatory Fibroblast
In 2030, elderly people will represent 20% of the United States population. Even now, chronic cardiac diseases, especially heart failure with preserved systolic function (HFpEF), are the most expensive DRGs for Medicare. Progressive interstitial fibrosis in the aging heart is well recognized as an i...
Guardado en:
| Publicado en: | J Mol Cell Cardiol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5600709/ https://ncbi.nlm.nih.gov/pubmed/28826664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yjmcc.2017.08.003 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|